articles for safe patient project drug safety

(0.005 seconds)

PCSK9 Inhibitor Monoclonal Antibodies For The Treatment...

Tue December 22nd, 2015

1. SUMMARY Monoclonal antibodies targeted against the proprotein convertase subtilisin kexin type 9 (PCSK9) protein increase the liver’s ability to remove low-density lipop...

https://www.cadth.ca/pcsk9-inhibitor-monoclonal-antibodies-treatment-hypercholesterolemia

safe patient project
hospital news patient safety
fda drug safety
drug safety
the new agenda safety
safety in the warehouse
personal safety tools
safety posters